Dr. Rishika Agarwal earned her PhD at the University of Basel studying 3D skin models, contributed to psoriasis therapies that reached Phase 2 clinical trials, and holds published research along with a patent on liposome surface functionalization—giving her hands-on scientific experience that goes beyond typical investing backgrounds. She also pushes for long-horizon investment in breakthrough science in India, favors skincare and biology-backed products that can point to one clear molecule and mechanism with real evidence, and stays active in research communities through volunteer leadership roles at Nucleate and Graduate Women in Science.